BAUSCH + LOMB CORP (BLCO)
CA0717051076 - Common Stock
BLCO Crosses Below Key Moving Average Level
Bausch + Lomb Bolsters Pipeline with Acquisition of Whitecap Biosciences
Bausch + Lomb Launches enVista Aspire™ Intermediate Optimized Monofocal and Toric Intraocular Lenses in the European Union
Bausch + Lomb and Glaucoma Research Foundation Launch Second Annual “Faces of Glaucoma” Campaign and Fundraising Challenge
Bausch + Lomb to Participate in the 43rd Annual J.P. Morgan Healthcare Conference
Bausch + Lomb Confirms It Is Exploring a Potential Sale
Bausch + Lomb said it authorized management and advisers to explore a potential sale of the eye health company after shares dropped over reports of faltering deal talks with a group of private equity firms.
Bausch + Lomb Responds to Rumors of a Potential Sale
Bausch + Lomb Acquires Elios Vision, Significantly Enhances Glaucoma Treatment Capabilities
Bausch + Lomb Announces Third-Quarter 2024 Results
Banks, Private Credit Vie for $5 Billion Bausch + Lomb Financing
Banks and private credit firms are competing to provide at least $5 billion of debt financing to help fund a potential buyout of Bausch + Lomb, according to people with knowledge of the matter.
Why Bausch + Lomb Stock Soared by Over 7% on Monday
It was quite a busy and eventful day for the company.
Bausch + Lomb Receives FDA Approval for enVista® Envy™ Full Range of Vision Intraocular Lens
Bausch + Lomb Will Release Third-Quarter 2024 Financial Results on October 30
Bausch + Lomb Launches Opal™ Digital Marketplace in the United States
Bausch Health Taps Jefferies to Refinance Debt, Aid Spinoff
Bausch Health Cos. is working with Jefferies Financial Group to explore refinancing some of its debt to aid a long-planned spinoff of its stake in the eye-care company Bausch + Lomb, according to people with knowledge of the situation.
Why Bausch + Lomb Rallied Today
The highly indebted healthcare stock rose on rumors it may be selling itself.
Bausch Reportedly Explores A Sale; Could Alcon, J&J Or AbbVie Buy It?
Bausch + Lomb is reportedly considering a sale. But its potential acquirers could come up against antitrust concerns.
Bausch + Lomb Soars on Report That It’s Exploring a Sale
Bausch + Lomb Corp. shares rose the most ever following a report that the eye-care company is considering selling itself to disentangle from its debt-laden parent company.
Thursday 8/8 Insider Buying Report: NINE, BLCO
Top Buys by Directors: Saunders's $505.1K Bet on BLCO
Top Buys by Top Brass: CEO and Chairman of the Board Saunders's $505.1K Bet on BLCO
Bausch + Lomb (BLCO) Shares Cross Below 200 DMA
